BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 9:38:18 AM | Browse: 282 | Download: 563
Publication Name World Journal of Clinical Oncology
Manuscript ID 76264
Country/Territory Greece
Received
2022-03-09 10:59
Peer-Review Started
2022-03-09 11:01
To Make the First Decision
Return for Revision
2022-04-17 10:20
Revised
2022-05-10 09:20
Second Decision
2022-06-27 03:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-06-27 18:58
Articles in Press
2022-06-27 18:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-06-22 02:29
Typeset the Manuscript
2022-07-01 08:12
Publish the Manuscript Online
2022-07-22 09:38
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Review
Article Title Nanomedicine approaches for treatment of hematologic and oncologic malignancies
Manuscript Source Invited Manuscript
All Author List Polyxeni Nteli, Danae Efremia Bajwa, Dimitrios Politakis, Charalampos Michalopoulos, Anastasia Kefala-Narin, Efstathios P Efstathopoulos and Maria Gazouli
ORCID
Author(s) ORCID Number
Maria Gazouli http://orcid.org/0000-0002-3295-6811
Funding Agency and Grant Number
Corresponding Author Maria Gazouli, PhD, Professor, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, Michalakopoulou 176, Athens 11527, Greece. mgazouli@med.uoa.gr
Key Words Nanomedicine; Cancer; Immunotherapy; Gene; Cell therapy
Core Tip Despite many years of fundamental and clinical examination and preliminaries of promising new treatments, cancer stays a significant reason for dreariness and mortality. Ongoing investigations propose that nanomedicine gives benefits over conventional treatments for cancer therapy. Immunotherapeutic strategies, such as cancer vaccines, immunomodulatory agents, immune checkpoint inhibitors, natural killer cells, peptides, nucleic acids, and chimeric antigen receptor T-cells, have augmented the development of this treatment either by stimulating cells or blocking the so-called immune checkpoint pathways. The efficacy of nanomedicine treatments and the examination of the advancement in the synergistic plan of immune-targeting combination therapies reviewed in this manuscript have been validated in clinical trials. The field of nanomedicine, therefore, generates new approaches regarding oncologic malignancies.
Publish Date 2022-07-22 09:38
Citation Nteli P, Bajwa DE, Politakis D, Michalopoulos C, Kefala-Narin A, Efstathopoulos EP, Gazouli M. Nanomedicine approaches for treatment of hematologic and oncologic malignancies. World J Clin Oncol 2022; 13(7): 553-566
URL https://www.wjgnet.com/2218-4333/full/v13/i7/553.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i7.553
Full Article (PDF) WJCO-13-553.pdf
Full Article (Word) WJCO-13-553.docx
Manuscript File 76264_Auto_Edited-LM.docx
Answering Reviewers 76264-Answering reviewers.pdf
Audio Core Tip 76264-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 76264-Conflict-of-interest statement.pdf
Copyright License Agreement 76264-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 76264-Language certificate.pdf
Peer-review Report 76264-Peer-review(s).pdf
Scientific Misconduct Check 76264-Bing-Wang LL-2.png
Scientific Editor Work List 76264-Scientific editor work list.pdf